Junshi Biosciences says contributed JV assets valued at RMB 53.08 million in supplemental announcement
I'm LongbridgeAI, I can summarize articles.Shanghai Junshi Biosciences issued a supplemental announcement clarifying its joint venture transaction. Independent valuer Zhongfa assessed contributed assets at RMB 53.08 million, comprising RMB 2.19 million in intangible assets and RMB 50.89 million in fixed assets. In exchange for these assets, Junshi received a 14.55% equity stake in the JV. The implied subscription price was approximately RMB 212.32 per unit of registered capital.
- Shanghai Junshi Biosciences issued a supplemental clarification on a connected JV transaction, detailing asset valuation and pricing basis. * Independent valuer Zhongfa used a cost approach, valuing contributed intangible assets at RMB 2.19 million, fixed assets at RMB 50.89 million. * Total appraised value of contributed assets set at RMB 53.08 million, exchanged for a 14.55% equity stake in the JV. * Implied subscription price for Junshi at about RMB 212.32 per RMB 1 of new registered capital; angel investors priced at RMB 218.87. * JV net asset value reported as nil; founding shareholders subscribed RMB 830,000 at par, with payment targeted by June 30, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Junshi Biosciences Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260626-12219274), on June 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)